Jover Placid sold $447K of TEVA
Jover Placid (See "Remarks") sold 12,827 shares of TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA) at $34.88 ($0.45M total) on 2026-08-03 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The newest fact is the specific sale size, price, and total value, plus confirmation that it was executed under a pre-arranged 10b5-1 plan.
Market read
Traders may note the disclosed insider sale, but the 10b5-1 structure generally limits actionable fundamental impact.
What to watch
The article provides no context on overall insider holdings, whether sales are part of scheduled diversification, or whether other insiders are buying.
Background
The article is an SEC Form 4 insider transaction disclosure for TEVA, reported by officer Jover Placid.
Ticker impact
Form 4 shows insider Jover Placid sold 12,827 TEVA shares on 2026-08-03 at $34.8757, totaling about $447.4K.
Low likelihood of a sustained price move; any reaction is likely short-lived and sentiment-driven.
The filing is a Form 4 insider transaction and explicitly notes a pre-arranged 10b5-1 plan, which typically reduces interpretive weight versus discretionary selling.
Market effects
No sector-level implications; this is company-specific insider trading disclosure.
None indicated.
None indicated.
Counterpoint
Even with 10b5-1, repeated insider selling can still be monitored as a weak sentiment signal if it clusters with other negative disclosures.
Key entities
- issuerTEVA PHARMACEUTICAL INDUSTRIES LTD
Subject of the Form 4 insider transaction disclosure.
- insiderJover Placid
Officer who sold 12,827 shares of TEVA under a 10b5-1 plan.
